MASH Treatment Global Market Opportunities And Strategies To 2034

MASH Treatment Market 2025 – By Treatment (Drug, Therapy), By Disease Stage (Simple Fatty Liver / MASLD (No Or Mild Fibrosis), Early MASH (Significant/Advanced Fibrosis), Fibrotic MASH, MASH Cirrhosis And Liver Failure / Liver Cancer Mortality), By End-User (Hospitals, Specialty Clinics, Homecare, Other End-User), And By Region, Opportunities And Strategies – Global Forecast To 2035

MASH Treatment Global Market Opportunities And Strategies To 2034

Report Price : $4490.00 $3367.00 | Pages : 312 | Published : September 2025 | Delivery Time: Immediately Info icon | Format : pdf icon

Purchase Options
Request a Sample
Request For Discount
Customise Your Report
Item added to cart!
Request For Regional Data
MASH Treatment Global Market Opportunities And Strategies To 2034
Description Table Of Contents Tables & Figures

Market Insights

Related Reports

MASH Treatment Market Definition

Metabolic dysfunction-associated steatohepatitis (MASH), previously known as non-alcoholic steatohepatitis (NASH), is a chronic and progressive liver disease characterized by fat accumulation, inflammation and fibrosis in the liver, primarily linked to obesity, insulin resistance, type 2 diabetes and other metabolic disorders. The primary purpose of metabolic dysfunction-associated steatohepatitis (MASH) treatment is to halt or reverse liver damage, prevent disease progression to cirrhosis or liver failure, and manage associated metabolic conditions. The treatment typically includes lifestyle interventions, pharmacotherapy, and in some cases, surgical options to reduce liver inflammation, fibrosis, and metabolic risk factors.

The MASH treatment market consists of sales by entities (organizations, sole traders and partnerships) of MASH treatment drugs and therapy that is used when lifestyle modifications alone are insufficient to halt or reverse liver damage. It is utilized across a continuum of care, beginning with non-invasive interventions and progressing to pharmacological treatment or bariatric surgery in advanced cases.

MASH Treatment Global Market Opportunities And Strategies To 2034 Market Size and growth rate 2025 to 2029: Graph

MASH Treatment Market Size

The global MASH treatment market reached a value of nearly $2,597.53 million in 2024, having grown at a compound annual growth rate (CAGR) of 21.55% since 2019. The market is expected to grow from $2,597.53 million in 2024 to $7,045.26 million in 2029 at a rate of 22.09%. The market is then expected to grow at a CAGR of 21.53% from 2029 and reach $18,679.22 million in 2034.

Growth in the historic period resulted from the rising research and development (R&D) spending in life sciences, rising demand for personalized medicine, supportive government initiatives and growing awareness and screening programs. Factors that negatively affected growth in the historic period were stringent and complex regulatory requirements and limited awareness among general population.

Going forward, growing interest in combination therapies, increasing incidence of non-alcoholic fatty liver disease (NAFLD), rising demand for liver transplants and growing prevalence of obesity will drive the growth. Factor that could hinder the growth of the MASH treatment market in the future include high cost of emerging treatments, limited biomarker availability and impact of trade war and tariffs.  

MASH Treatment Market Drivers

The key drivers of the MASH treatment market include:

Rising Demand For Liver Transplants

Rising demand for liver transplants is expected to be a key driver of the growth of the MASH treatment market in the forecast period. As MASH progresses, it can lead to advanced fibrosis, cirrhosis and liver failure, making transplantation the only viable option for many patients. However, the shortage of donor livers, high costs and post-transplant complications have intensified the need for effective pharmacological interventions that can halt or reverse disease progression before transplantation becomes necessary. This urgency has spurred accelerated R&D in MASH therapeutics, with pharmaceutical companies focusing on anti-fibrotic, metabolic and anti-inflammatory drugs to prevent liver deterioration. Additionally, healthcare systems and insurers are increasingly incentivizing early treatment to reduce the long-term burden of transplant-related expenses.  The rising demand for liver transplants growth contribution during the forecast period in 2024 is 0.50%.

MASH Treatment Market Restraints

The key restraints on the MASH treatment market include:

High Cost Of Emerging Treatments

High cost of emerging treatments is restricting the growth of the MASH treatment market during the forecast period. Novel MASH drugs, such as FXR agonists, THR-ß modulators and combination therapies, often carry premium price tags due to extensive R&D investments, complex clinical trials and the need for long-term efficacy and safety data. Many healthcare systems, particularly in cost-sensitive markets, are hesitant to reimburse these expensive therapies without demonstrable long-term benefits (e.g., reduced liver transplants or mortality). The lack of cost-effective diagnostic tools for widespread screening means fewer patients are identified early, further limiting the eligible treatment pool.  Growth affected by high cost of emerging treatments during the forecast period in 2024 is -1.95%.

MASH Treatment Market Trends

Major trends shaping the MASH treatment market include:

Integration Of Artificial Intelligence (AI) In MASH Treatment

Major companies operating in the MASH treatment market are focusing on integration of artificial intelligence (AI) in MASH treatment market to enhance precision in disease assessment and treatment outcomes. Companies are increasingly leveraging AI to support non-invasive, accurate evaluation of liver fibrosis, a key factor in MASH progression. For instance, in March 2025, HistoIndex, a Singapore based company engaged in stain-free digital pathology solutions for managing fibrotic diseases, has announced the launch of their first Laboratory Developed Test (LDT) FibroSIGHT. FibroSIGHT seamlessly integrates into routine clinical workflows, leveraging on HistoIndex’s proprietary stain-free imaging technology to enhance the sensitivity of fibrillar collagens detection — key in evaluating fibrosis severity in liver biopsy samples. By eliminating variability associated with traditional staining techniques, FibroSIGHT delivers reliable and precise fibrosis assessment for MASH patients.  Also, in February 2025, Insilico Medicine, a US based clinical-stage generative artificial intelligence (AI)-driven drug discovery company, achieved preclinical milestone in its collaboration with Therasid Bioscience, a South Korean based biotechnology company focuses on developing innovative first-in-class drugs for treatment for metabolic dysfunction-associated steatohepatitis (MASH). Insilico's team synthesized and tested approximately 40 molecules by leveraging its proprietary AI-powered generative chemistry engine, Chemistry42.

Strategic Partnerships And Collaborations Among Market Players

Companies in the MASH treatment market are adopting a strategic partnership approach for business expansion in the market. Strategic partnerships enable companies to leverage each other's strengths and resources to achieve mutual benefits and success.  For example, in April 2024, Boehringer, a Germany-based pharmaceutical company actively involved in developing treatments for metabolic dysfunction-associated steatohepatitis (MASH), entered a multi-year collaboration with Ochre Bio, a UK-based biotech, to develop RNA therapies targeting chronic liver diseases, with a primary focus on MASH. The deal includes $35 million upfront and potential milestones exceeding $1 billion. The partnership aim is to identify, characterize and validate multiple novel regenerative targets that could enhance the liver’s self-repair capabilities, potentially halting or reversing disease progression in MASH and other chronic liver diseases.  Further, in January 2024, Suzhou Ribo Life Science Co., Ltd., a China-based clinical-stage company and Ribocure Pharmaceuticals AB (Ribo), a Sweden-based clinical-stage biotechnology company, announced a collaboration with Boehringer Ingelheim for $2 billion. This partnership aims to develop innovative treatments for nonalcoholic steatohepatitis (NASH) and metabolic dysfunction-associated steatohepatitis (MASH) by combining Ribo’s RNAi therapeutic platform with Boehringer Ingelheim’s expertise in cardiovascular, renal and metabolic diseases. The collaboration focuses on addressing the urgent need for effective therapies to halt NASH progression and restore liver function. Boehringer Ingelheim is a Germany-based pharmaceutical company actively involved in developing treatments for metabolic dysfunction-associated steatohepatitis (MASH).

Opportunities And Recommendations In The MASH Treatment Market

Opportunities – The top opportunities in the MASH treatment market segmented by treatment will arise in the drug segment, which will gain $3,674.70 million of global annual sales by 2029. The top opportunities in the MASH treatment market segmented by end-user will arise in the hospitals segment, which will gain $2,081.26 million of global annual sales by 2029. The top opportunities in the MASH treatment market segmented by disease stage will arise in the early MASH (significant/advanced fibrosis) segment, which will gain $2,098.32 million of global annual sales by 2029. The MASH treatment market size will gain the most in the USA at $1,689.67 million.

Recommendations- To take advantage of the opportunities, The Business Research Company recommends the MASH treatment market companies to Focus on Advancing FGF21-Based Therapies to Address MASH and Broader Liver Conditions, Focus on Integrating AI to Improve Diagnostic Accuracy and Drug Discovery in MASH, Focus on Drug Segment to Maximize Growth in MASH Treatment Market, Expand In Emerging Markets, Continue To Focus On Developed Markets, Provide Competitively Priced Offerings, Continue To Use B2B Promotions, Focus on Strategic Partnerships to Accelerate Innovation and Expand Market Reach, Focus on Specialty Clinics to Capture Highest-Growth End-User Segment.

chesta image

Book your 30 minutes free consultation with our research experts

Contact Us

MASH TreatmentMarket Segmentation

The MASH treatment market is segmented by treatment, by disease stage and by end user



By Treatment –


The MASH treatment market is segmented by treatment into:

    • a) Drug

    • b) Therapy

The drug market was the largest segment of the MASH treatment market segmented by treatment, accounting for 78.58% or $2,041.25 million of the total in 2024. Going forward, the drug segment is expected to be the fastest growing segment in the MASH treatment market segmented by treatment, at a CAGR of 22.87% during 2024-2029.



By Disease Stage –


The MASH treatment market is segmented by disease stage into:

    • a) Simple Fatty Liver / MASLD (No Or Mild Fibrosis)

    • b) Early MASH (Significant/Advanced Fibrosis)

    • c) Fibrotic MASH

    • d) MASH Cirrhosis

    • d) Liver Failure / Liver Cancer Mortality

The early MASH (significant/advanced fibrosis) market was the largest segment of the MASH treatment market segmented by disease stage, accounting for 34.83% or $904.74 million of the total in 2024. Going forward, the early MASH (significant/advanced fibrosis), fibrotic MASH segment is expected to be the fastest growing segment in the MASH treatment market segmented by disease stage, at a CAGR of 27.12% during 2024-2029.



By End User–


The MASH treatment market is segmented by end user into:

    • a) Hospitals

    • b) Specialty Clinics

    • b) Homecare

    • b) Other End-User

The hospitals market was the largest segment of the MASH treatment market segmented by end-user, accounting for 49.09% or $1,275.05 million of the total in 2024. Going forward, the specialty clinics segment is expected to be the fastest growing segment in the MASH treatment market segmented by end-user, at a CAGR of 23.56% during 2024-2029.



By Geography - The MASH treatment market is segmented by geography into:

      o Asia Pacific

      • • China

      • • India

      • • Japan

      • • Australia

      • • Indonesia

      • • South Korea

      o North America

      • • USA

      • • Canada

      o South America

      • • Brazil

      o Western Europe

      • • France

      • • Germany

      • • UK

      • • Italy

      • • Spain

      o Eastern Europe

      • • Russia

      o Middle East

      o Africa

North America was the largest region in the MASH treatment market, accounting for 46.13% or $1,198.35 million of the total in 2024. It was followed by Asia Pacific, Western Europe and then the other regions. Going forward, the fastest-growing regions in the MASH treatment market will be Asia Pacific and North America where growth will be at CAGRs of 27.73% and 20.93% respectively. These will be followed by Africa and South America where the markets are expected to grow at CAGRs of 19.47% and 19.15% respectively.

MASH treatment Market Competitive Landscape

Major Competitors are:

  • Madrigal Pharmaceuticals Inc

  • Novo Nordisk A/S (IGT)

  • Eli Lilly Company

  • AstraZeneca plc

  • Mayo Clinic

    • Other Competitors Include:

  • Zydus Lifesciences

  • King’s College Hospital

  • Johns Hopkins Hospital

  • Imperial College Healthcare NHS Trust

  • Cleveland Clinic

  •  Zhejiang Doer Biologics

  • Cadila Healthcare (Zydus)

  • Sun Pharma

  • Suzhou Ribo Life Science

  • Ribocure AB

  • Boehringer Ingelheim

  • Inventiva

  • Takeda Pharmaceutical Company

  • Insilico Medicine

  • Therasid Bioscience

  • OliX Pharmaceuticals

  • Suzhou Ribo Life Science

  • Genflow Biosciences

  • Pfizer Inc.

  • PathAI

  •  Gilead Sciences Inc.

  •  Alimentiv Inc.

  • Galectin Therapeutics Inc

  • Labcorp

  • Quest Diagnostics

  • Rivus Pharmaceuticals

  • TARGET PharmaSolutions Inc

  • HighTide Biopharma Inc
    • Author : Abhilash Pyata

      Table Of Contents

      1 Executive Summary

      1.1 MASH Treatment – Market Attractiveness And Macro Economic Landscape

      2 Table Of Contents

      3 List Of Tables

      4 List Of Figures

      5 Report Structure

      6 Market Characteristics

      6.1 General Market Definition

      6.2 Summary

      6.3 MASH Treatment Market Definition And Segmentations

      6.4 Market Segmentation By Treatment

      6.4.1 Drug

      6.4.2 Therapy

      6.5 Market Segmentation By Disease Stage

      6.5.1 Simple Fatty Liver / MASLD (No Or Mild Fibrosis)

      6.5.2 Early MASH (Significant/Advanced Fibrosis)

      6.5.3 Fibrotic MASH

      6.5.4 MASH Cirrhosis

      6.5.5 Liver Failure / Liver Cancer Mortality

      6.6 Market Segmentation By End-User

      6.6.1 Hospitals

      6.6.2 Specialty Clinics

      6.6.3 Homecare

      6.6.4 Other End-User

      7 Major Market Trends

      7.1 Advancements In Fibroblast Growth Factors (FGFs) Through Acquisitions

      7.2 Integration Of Artificial Intelligence (AI) In MASH Treatment

      7.3 Strategic Partnerships And Collaborations Among Market Players

      7.4 Focus On Receiving Government Approvals To Highlight Advancements in MASH Treatment

      7.5 Innovative MASH Treatments Address Fibrosis And Improve Liver Health Outcomes

      8 MASH Treatment Growth Analysis And Strategic Analysis Framework

      8.1 Global MASH Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors)

      8.1.1 Political

      8.1.2 Economic

      8.1.3 Social

      8.1.4 Technological

      8.1.5 Environmental

      8.1.6 Legal

      8.2 Analysis Of End User Industries (B2B)

      8.2.1 Hospitals

      8.2.2 Specialty Clinics

      8.2.3 Homecare

      8.2.4 Other End-User

      8.3 MASH Treatment Market Growth Rate Analysis

      8.4 Historic Market Growth, 2019 – 2024, Value ($ Million)

      8.4.1 Market Drivers 2019 – 2024

      8.4.2 Market Restraints 2019 – 2024

      8.5 Forecast Market Growth, 2024 – 2029, 2034F Value ($ Million)

      8.6 Forecast Growth Contributors/Factors

      8.6.1 Quantitative Growth Contributors

      8.6.2 Drivers

      8.6.3 Restraints

      8.7 MASH Treatment Total Addressable Market (TAM)

      9 MASH Treatment Market Segmentation

      9.1 MASH Treatment Market, Segmentation By Treatment, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      9.2 MASH Treatment Market, Segmentation By End-User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      9.3 MASH Treatment Market, Segmentation By Disease Stage, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      9.4 MASH Treatment Market, Sub-Segmentation Of Drug, By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      9.5 MASH Treatment Market, Sub-Segmentation Of Therapy, By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      10 MASH Treatment Market, Regional and Country Analysis

      10.1 MASH Treatment Market, By Region, Historic and Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      10.2 MASH Treatment Market, By Country, Historic and Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      11 Asia-Pacific Market

      11.1 Summary

      11.2 Market Overview

      11.2.1 Region Information

      11.2.2 Market Information

      11.2.3 Background Information

      11.2.4 Government Initiatives

      11.2.5 Regulations

      11.2.6 Regulatory Bodies

      11.2.7 Major Associations

      11.2.8 Taxes Levied

      11.2.9 Corporate Tax Structure

      11.2.10 Investments

      11.2.11 Major Companies

      11.3 Asia-Pacific MASH Treatment Market, Segmentation By Treatment, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      11.4 Asia-Pacific MASH Treatment Market, Segmentation By End-User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      11.5 Asia-Pacific MASH Treatment Market, Segmentation By Disease Stage, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      11.6 Asia-Pacific MASH Treatment Market: Country Analysis

      11.7 China Market

      11.8 Summary

      11.9 Market Overview

      11.9.1 Country Information

      11.9.2 Market Information

      11.9.3 Background Information

      11.9.4 Government Initiatives

      11.9.5 Regulations

      11.9.6 Regulatory Bodies

      11.9.7 Major Associations

      11.9.8 Taxes Levied

      11.9.9 Corporate Tax Structure

      11.9.10 Investments

      11.9.11 Major Companies

      11.10 China MASH Treatment Market, Segmentation By Treatment, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      11.11 China MASH Treatment Market, Segmentation By End-User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      11.12 China MASH Treatment Market, Segmentation By Disease Stage, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      11.13 India Market

      11.14 India MASH Treatment Market, Segmentation By Treatment, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      11.15 India MASH Treatment Market, Segmentation By End-User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      11.16 India MASH Treatment Market, Segmentation By Disease Stage, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      11.17 Japan Market

      11.18 Summary

      11.19 Market Overview

      11.19.1 Country Information

      11.19.2 Market Information

      11.19.3 Background Information

      11.19.4 Government Initiatives

      11.19.5 Regulations

      11.19.6 Regulatory Bodies

      11.19.7 Major Associations

      11.19.8 Taxes Levied

      11.19.9 Corporate Tax Structure

      11.19.10 Investments

      11.19.11 Major Companies

      11.20 Japan MASH Treatment Market, Segmentation By Treatment, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      11.21 Japan MASH Treatment Market, Segmentation By End-User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      11.22 Japan MASH Treatment Market, Segmentation By Disease Stage, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      11.23 Australia Market

      11.24 Australia MASH Treatment Market, Segmentation By Treatment, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      11.25 Australia MASH Treatment Market, Segmentation By End-User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      11.26 Australia MASH Treatment Market, Segmentation By Disease Stage, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      11.27 Indonesia Market

      11.28 Indonesia MASH Treatment Market, Segmentation By Treatment, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      11.29 Indonesia MASH Treatment Market, Segmentation By End-User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      11.30 Indonesia MASH Treatment Market, Segmentation By Disease Stage, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      11.31 South Korea Market

      11.32 Summary

      11.33 Market Overview

      11.33.1 Country Information

      11.33.2 Market Information

      11.33.3 Background Information

      11.33.4 Government Initiatives

      11.33.5 Regulations

      11.33.6 Regulatory Bodies

      11.33.7 Major Associations

      11.33.8 Taxes Levied

      11.33.9 Corporate Tax Structure

      11.33.10 Investments

      11.33.11 Major Companies

      11.34 South Korea MASH Treatment Market, Segmentation By Treatment, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      11.35 South Korea MASH Treatment Market, Segmentation By End-User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      11.36 South Korea MASH Treatment Market, Segmentation By Disease Stage, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      12 Western Europe Market

      12.1 Summary

      12.2 Market Overview

      12.2.1 Region Information

      12.2.2 Market Information

      12.2.3 Background Information

      12.2.4 Government Initiatives

      12.2.5 Regulations

      12.2.6 Regulatory Bodies

      12.2.7 Major Associations

      12.2.8 Taxes Levied

      12.2.9 Corporate tax structure

      12.2.10 Investments

      12.2.11 Major Companies

      12.3 Western Europe MASH Treatment Market, Segmentation By Treatment, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      12.4 Western Europe MASH Treatment Market, Segmentation By End-User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      12.5 Western Europe MASH Treatment Market, Segmentation By Disease Stage, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      12.6 Western Europe MASH Treatment Market: Country Analysis

      12.7 UK Market

      12.8 UK MASH Treatment Market, Segmentation By Treatment, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      12.9 UK MASH Treatment Market, Segmentation By End-User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      12.10 UK MASH Treatment Market, Segmentation By Disease Stage, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      12.11 Germany Market

      12.12 Germany MASH Treatment Market, Segmentation By Treatment, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      12.13 Germany MASH Treatment Market, Segmentation By End-User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      12.14 Germany MASH Treatment Market, Segmentation By Disease Stage, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      12.15 France Market

      12.16 France MASH Treatment Market, Segmentation By Treatment, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      12.17 France MASH Treatment Market, Segmentation By End-User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      12.18 France MASH Treatment Market, Segmentation By Disease Stage, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      12.19 Italy Market

      12.20 Italy MASH Treatment Market, Segmentation By Treatment, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      12.21 Italy MASH Treatment Market, Segmentation By End-User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      12.22 Italy MASH Treatment Market, Segmentation By Disease Stage, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      12.23 Spain Market

      12.24 Spain MASH Treatment Market, Segmentation By Treatment, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      12.25 Spain MASH Treatment Market, Segmentation By End-User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      12.26 Spain MASH Treatment Market, Segmentation By Disease Stage, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      13 Eastern Europe Market

      13.1 Summary

      13.2 Market Overview

      13.2.1 Region Information

      13.2.2 Market Information

      13.2.3 Background Information

      13.2.4 Government Initiatives

      13.2.5 Regulations

      13.2.6 Regulatory Bodies

      13.2.7 Major Associations

      13.2.8 Taxes Levied

      13.2.9 Corporate Tax Structure

      13.2.10 Major companies

      13.3 Eastern Europe MASH Treatment Market, Segmentation By Treatment, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      13.4 Eastern Europe MASH Treatment Market, Segmentation By End-User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      13.5 Eastern Europe MASH Treatment Market, Segmentation By Disease Stage, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      13.6 Eastern Europe MASH Treatment Market: Country Analysis

      13.7 Russia Market

      13.8 Russia MASH Treatment Market, Segmentation By Treatment, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      13.9 Russia MASH Treatment Market, Segmentation By End-User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      13.10 Russia MASH Treatment Market, Segmentation By Disease Stage, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      14 North America Market

      14.1 Summary

      14.2 Market Overview

      14.2.1 Region Information

      14.2.2 Market Information

      14.2.3 Background Information

      14.2.4 Government Initiatives

      14.2.5 Regulations

      14.2.6 Regulatory Bodies

      14.2.7 Major Associations

      14.2.8 Taxes Levied

      14.2.9 Corporate Tax Structure

      14.2.10 Investments

      14.2.11 Major Companies

      14.3 North America MASH Treatment Market, Segmentation By Treatment, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      14.4 North America MASH Treatment Market, Segmentation By End-User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      14.5 North America MASH Treatment Market, Segmentation By Disease Stage, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      14.6 North America MASH Treatment Market: Country Analysis

      14.7 USA Market

      14.8 Summary

      14.9 Market Overview

      14.9.1 Country Information

      14.9.2 Market Information

      14.9.3 Background Information

      14.9.4 Government Initiatives

      14.9.5 Regulations

      14.9.6 Regulatory Bodies

      14.9.7 Major Associations

      14.9.8 Taxes Levied

      14.9.9 Corporate Tax Structure

      14.9.10 Investments

      14.9.11 Major Companies

      14.10 USA MASH Treatment Market, Segmentation By Treatment, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      14.11 USA MASH Treatment Market, Segmentation By End-User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      14.12 USA MASH Treatment Market, Segmentation By Disease Stage, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      14.13 Canada Market

      14.14 Summary

      14.15 Market Overview

      14.15.1 Country Information

      14.15.2 Market Information

      14.15.3 Background Information

      14.15.4 Government Initiatives

      14.15.5 Regulations

      14.15.6 Regulatory Bodies

      14.15.7 Major Associations

      14.15.8 Taxes Levied

      14.15.9 Corporate Tax Structure

      14.15.10 Investments

      14.15.11 Major Companies

      14.16 Canada MASH Treatment Market, Segmentation By Treatment, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      14.17 Canada MASH Treatment Market, Segmentation By End-User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      14.18 Canada MASH Treatment Market, Segmentation By Disease Stage, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      15 South America Market

      15.1 Summary

      15.2 Market Overview

      15.2.1 Region Information

      15.2.2 Market Information

      15.2.3 Background Information

      15.2.4 Government Initiatives

      15.2.5 Regulations

      15.2.6 Regulatory Bodies

      15.2.7 Major Associations

      15.2.8 Taxes Levied

      15.2.9 Corporate Tax Structure

      15.2.10 Major Companies

      15.3 South America MASH Treatment Market, Segmentation By Treatment, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      15.4 South America MASH Treatment Market, Segmentation By End-User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      15.5 South America MASH Treatment Market, Segmentation By Disease Stage, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      15.6 South America MASH Treatment Market: Country Analysis

      15.7 Brazil Market

      15.8 Brazil MASH Treatment Market, Segmentation By Treatment, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      15.9 Brazil MASH Treatment Market, Segmentation By End-User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      15.10 Brazil MASH Treatment Market, Segmentation By Disease Stage, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      16 Middle East Market

      16.1 Summary

      16.2 Market Overview

      16.2.1 Region Information

      16.2.2 Market Information

      16.2.3 Background Information

      16.2.4 Government Initiatives

      16.2.5 Regulations

      16.2.6 Regulatory Bodies

      16.2.7 Major Associations

      16.2.8 Taxes Levied

      16.2.9 Corporate Tax Structure

      16.2.10 Major Companies

      16.3 Middle East MASH Treatment Market, Segmentation By Treatment, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      16.4 Middle East MASH Treatment Market, Segmentation By End-User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      16.5 Middle East MASH Treatment Market, Segmentation By Disease Stage, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      17 Africa Market

      17.1 Summary

      17.2 Market Overview

      17.2.1 Region Information

      17.2.2 Market Information

      17.2.3 Background Information

      17.2.4 Government Initiatives

      17.2.5 Regulations

      17.2.6 Regulatory Bodies

      17.2.7 Major Associations

      17.2.8 Taxes Levied

      17.2.9 Corporate Tax Structure

      17.2.10 Major Companies

      17.3 Africa MASH Treatment Market, Segmentation By Treatment, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      17.4 Africa MASH Treatment Market, Segmentation By End-User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      17.5 Africa MASH Treatment Market, Segmentation By Disease Stage, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      18 Competitive Landscape And Company Profiles

      18.1 Company Profiles

      18.2 Madrigal Pharmaceuticals Inc.

      18.2.1 Company Overview

      18.2.2 Products And Services

      18.2.3 Business Strategy

      18.2.4 Financial Overview

      18.3 Novo Nordisk A/S

      18.3.1 Company Overview

      18.3.2 Products And Services

      18.3.3 Financial Overview

      18.4 Eli Lilly Company

      18.4.1 Company Overview

      18.4.2 Products And Services

      18.4.3 Business Strategy

      18.4.4 Financial Overview

      18.5 AstraZeneca plc

      18.5.1 Company Overview

      18.5.2 Products And Services

      18.5.3 Business Strategy

      18.5.4 Financial Overview

      18.6 Mayo Clinic

      18.6.1 Company Overview

      18.6.2 Products And Services

      18.6.3 Financial Overview

      19 Other Major And Innovative Companies

      19.1 Zydus Lifesciences

      19.1.1 Company Overview

      19.1.2 Products And Services

      19.2 King’s College Hospital

      19.2.1 Company Overview

      19.2.2 Products And Services

      19.3 Johns Hopkins Hospital

      19.3.1 Company Overview

      19.3.2 Products And Services

      19.4 Imperial College Healthcare NHS Trust

      19.4.1 Company Overview

      19.4.2 Products And Services

      19.5 Cleveland Clinic

      19.5.1 Company Overview

      19.5.2 Products And Services

      19.6 HighTide Therapeutics Inc.

      19.6.1 Company Overview

      19.6.2 Products And Services

      19.7 Sagimet Biosciences

      19.7.1 Company Overview

      19.7.2 Products And Services

      19.8 Rivus Pharmaceuticals

      19.8.1 Company Overview

      19.8.2 Products And Services

      19.9 89bio Inc.

      19.9.1 Company Overview

      19.9.2 Products And Services

      19.10 Dr. Falk Pharma

      19.10.1 Company Overview

      19.10.2 Products And Services

      19.11 Akero Therapeutics

      19.11.1 Company Overview

      19.11.2 Products And Services

      19.12 NorthSea Therapeutics BV

      19.12.1 Company Overview

      19.12.2 Products And Services

      19.13 Lipocine Inc.

      19.13.1 Company Overview

      19.13.2 Products And Services

      19.14 Cirius Therapeutics

      19.14.1 Company Overview

      19.14.2 Products And Services

      19.15 Alimentiv Inc.

      19.15.1 Company Overview

      19.15.2 Products And Services

      20 Competitive Benchmarking

      21 Competitive Dashboard

      22 Key Mergers And Acquisitions

      22.1 GlaxoSmithKline (GSK) Acquired efimosfermin From Boston Pharmaceuticals

      22.2 Gilead Sciences Acquired CymaBay Therapeutics

      23 Recent Developments In MASH Treatment

      23.1 Home-Based Therapeutic Approach Gains Traction In MASH Management

      23.2 Next-Gen FGF21 Therapy Under Investigation For MASH Management

      24 Opportunities And Strategies

      24.1 MASH Treatment Market In 2029 – Countries Offering Most New Opportunities

      24.2 MASH Treatment Market In 2029 – Segments Offering Most New Opportunities

      24.3 MASH Treatment Market In 2029 – Growth Strategies

      24.3.1 Market Trend Based Strategies

      24.3.2 Competitor Strategies

      25 MASH Treatment Market, Conclusions And Recommendations

      25.1 Conclusions

      25.2 Recommendations

      25.2.1 Product

      25.2.2 Place

      25.2.3 Price

      25.2.4 Promotion

      25.2.5 People

      26 Appendix

      26.1 Geographies Covered

      26.2 Market Data Sources

      26.3 Research Methodology

      26.4 Currencies

      26.5 The Business Research Company

      26.6 Copyright and Disclaimer

    List Of Tables

      Table 1: MASH Treatment Market, Historic, 2019 – 2024, $ Million
    • Table 2: MASH Treatment Market, Forecast, 2024 – 2029, 2034F , $ Million
    • Table 3: Global MASH Treatment Market TAM, 2024 And 2034, $ Million
    • Table 4: MASH Treatment Market, Segmentation By Treatment, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 5: MASH Treatment Market, Segmentation By End-User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 6: MASH Treatment Market, Segmentation By Disease Stage, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 7: MASH Treatment Market, Sub-Segmentation Of Drug, By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 8: MASH Treatment Market, Sub-Segmentation Of Therapy, By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 9: MASH Treatment Market, By Region, Historic and Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 10: MASH Treatment Market, By Country, Historic and Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 11: Asia-Pacific GDP Per Capita, By Country, 2019-2024, $
    • Table 12:  Asia-Pacific Population, By Country, 2019-2029, Millions
    • Table 13: Asia-Pacific MASH Treatment Market, Segmentation By Treatment, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 14: Asia-Pacific MASH Treatment Market, Segmentation By End-User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 15: Asia-Pacific MASH Treatment Market, Segmentation By Disease Stage, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 16: China GDP Per Capita, 2019-2024, $
    • Table 17:  China Population, 2019-2029, Millions
    • Table 18: China MASH Treatment Market, Segmentation By Treatment, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 19: China MASH Treatment Market, Segmentation By End-User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 20: China MASH Treatment Market, Segmentation By Disease Stage, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 21: India MASH Treatment Market, Segmentation By Treatment, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 22: India MASH Treatment Market, Segmentation By End-User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 23: India MASH Treatment Market, Segmentation By Disease Stage, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 24: Japan GDP Per Capita, 2018-2023, $
    • Table 25:  Japan Population, By Country, 2019-2029, Millions
    • Table 26: Japan MASH Treatment Market, Segmentation By Treatment, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 27: Japan MASH Treatment Market, Segmentation By End-User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 28: Japan MASH Treatment Market, Segmentation By Disease Stage, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 29: Australia MASH Treatment Market, Segmentation By Treatment, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 30: Australia MASH Treatment Market, Segmentation By End-User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 31: Australia MASH Treatment Market, Segmentation By Disease Stage, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 32: Indonesia MASH Treatment Market, Segmentation By Treatment, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 33: Indonesia MASH Treatment Market, Segmentation By End-User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 34: Indonesia MASH Treatment Market, Segmentation By Disease Stage, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 35: South Korea GDP Per Capita, 2019-2024, $
    • Table 36:  South Korea Population, 2019-2029, Millions
    • Table 37: South Korea MASH Treatment Market, Segmentation By Treatment, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 38: South Korea MASH Treatment Market, Segmentation By End-User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 39: South Korea MASH Treatment Market, Segmentation By Disease Stage, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 40: Western Europe GDP Per Capita, By Country, 2019-2024, $
    • Table 41:  Western Europe Population, By Country, 2019-2029, Millions
    • Table 42: Western Europe MASH Treatment Market, Segmentation By Treatment, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 43: Western Europe MASH Treatment Market, Segmentation By End-User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 44: Western Europe MASH Treatment Market, Segmentation By Disease Stage, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 45: UK MASH Treatment Market, Segmentation By Treatment, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 46: UK MASH Treatment Market, Segmentation By End-User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 47: UK MASH Treatment Market, Segmentation By Disease Stage, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 48: Germany MASH Treatment Market, Segmentation By Treatment, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 49: Germany MASH Treatment Market, Segmentation By End-User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 50: Germany MASH Treatment Market, Segmentation By Disease Stage, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 51: France MASH Treatment Market, Segmentation By Treatment, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 52: France MASH Treatment Market, Segmentation By End-User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 53: France MASH Treatment Market, Segmentation By Disease Stage, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 54: Italy MASH Treatment Market, Segmentation By Treatment, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 55: Italy MASH Treatment Market, Segmentation By End-User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 56: Italy MASH Treatment Market, Segmentation By Disease Stage, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 57: Spain MASH Treatment Market, Segmentation By Treatment, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 58: Spain MASH Treatment Market, Segmentation By End-User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 59: Spain MASH Treatment Market, Segmentation By Disease Stage, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 60: Eastern Europe GDP Per Capita, By Country, 2019-2024, $
    • Table 61:  Eastern Europe Population, By Country, 2019-2029, Millions
    • Table 62: Eastern Europe MASH Treatment Market, Segmentation By Treatment, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 63: Eastern Europe MASH Treatment Market, Segmentation By End-User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 64: Eastern Europe MASH Treatment Market, Segmentation By Disease Stage, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 65: Russia MASH Treatment Market, Segmentation By Treatment, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 66: Russia MASH Treatment Market, Segmentation By End-User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 67: Russia MASH Treatment Market, Segmentation By Disease Stage, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 68: North America GDP Per Capita, By Country, 2019-2024, $
    • Table 69:  North America Population, By Country, 2019-2029, Millions
    • Table 70: North America MASH Treatment Market, Segmentation By Treatment, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 71: North America MASH Treatment Market, Segmentation By End-User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 72: North America MASH Treatment Market, Segmentation By Disease Stage, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 73: USA GDP Per Capita, 2019-2024, $
    • Table 74:  USA Population, 2019-2029, Millions
    • Table 75: USA MASH Treatment Market, Segmentation By Treatment, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 76: USA MASH Treatment Market, Segmentation By End-User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 77: USA MASH Treatment Market, Segmentation By Disease Stage, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 78: Canada GDP Per Capita, 2019-2024, $
    • Table 79:  Canada Population, By Country, 2019-2029, Millions
    • Table 80: Canada MASH Treatment Market, Segmentation By Treatment, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 81: Canada MASH Treatment Market, Segmentation By End-User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 82: Canada MASH Treatment Market, Segmentation By Disease Stage, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 83: South America GDP Per Capita, By Country, 2019-2024, $
    • Table 84:  South America Population, By Country, 2019-2029, Millions
    • Table 85: South America MASH Treatment Market, Segmentation By Treatment, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 86: South America MASH Treatment Market, Segmentation By End-User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 87: South America MASH Treatment Market, Segmentation By Disease Stage, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 88: Brazil MASH Treatment Market, Segmentation By Treatment, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 89: Brazil MASH Treatment Market, Segmentation By End-User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 90: Brazil MASH Treatment Market, Segmentation By Disease Stage, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 91: Middle East GDP Per Capita, By Country, 2019-2024, $
    • Table 92:  Middle East Population, By Country, 2019-2029, Millions
    • Table 93: Middle East MASH Treatment Market, Segmentation By Treatment, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 94: Middle East MASH Treatment Market, Segmentation By End-User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 95: Middle East MASH Treatment Market, Segmentation By Disease Stage, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 96: Africa GDP Per Capita, By Country, 2018-2023, $
    • Table 97:  Africa Population, By Country, 2018-2028, Millions
    • Table 98: Africa MASH Treatment Market, Segmentation By Treatment, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 99: Africa MASH Treatment Market, Segmentation By End-User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 100: Africa MASH Treatment Market, Segmentation By Disease Stage, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 101: Global MASH Treatment Market, Key Competitor Estimated Market Shares, 2024, Percentage (%)
    • Table 102: Mayo Clinic – Financial Overview, 2024, $ Billion
    • Table 103: MASH Treatment Market, Competitive Benchmarking (In USD Millions)
    • Table 104: MASH Treatment Market, Competitive Dashboard
    • Table 105: MASH Treatment Market Size Gain ($ Million), 2024 – 2029, By Country
    • Table 106: MASH Treatment Market Size Gain ($ Million), Segmentation By Treatment, 2024 – 2029
    • Table 107: MASH Treatment Market Size Gain ($ Million), Segmentation By End-User, 2024 – 2029
    • Table 108: MASH Treatment Market Size Gain ($ Million), Segmentation By Disease Stage, 2024 – 2029
    • Table 109: MASH Treatment Market Data Sources

    List Of Figures

      Figure 1: Global MASH Treatment Market Segmentation By Treatment
    • Figure 2: Global MASH Treatment Market Segmentation By Disease Stage
    • Figure 3: Global MASH Treatment Market Segmentation By End-User
    • Figure 4: Global MASH Treatment Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
    • Figure 5: MASH Treatment Market, Historic, 2019 – 2024, $ Million
    • Figure 6: MASH Treatment Market, Forecast, 2024 – 2029, 2034F , $ Million
    • Figure 7: MASH Treatment Market, Segmentation By Treatment, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 8: MASH Treatment Market, Segmentation By End-User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 9: MASH Treatment Market, Segmentation By Disease Stage, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 10: MASH Treatment Market, Sub-Segmentation Of Drug, By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 11: MASH Treatment Market, Sub-Segmentation Of Therapy, By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 12: MASH Treatment Market, By Region, Historic and Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 13: MASH Treatment Market, By Country, Historic and Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 14: Asia-Pacific MASH Treatment Market, Segmentation By Treatment, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 15: Asia-Pacific MASH Treatment Market, Segmentation By End-User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 16: Asia-Pacific MASH Treatment Market, Segmentation By Disease Stage, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 17: China MASH Treatment Market, Segmentation By Treatment, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 18: China MASH Treatment Market, Segmentation By End-User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 19: China MASH Treatment Market, Segmentation By Disease Stage, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 20: India MASH Treatment Market, Segmentation By Treatment, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 21: India MASH Treatment Market, Segmentation By End-User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 22: India MASH Treatment Market, Segmentation By Disease Stage, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 23: Japan MASH Treatment Market, Segmentation By Treatment, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 24: Japan MASH Treatment Market, Segmentation By End-User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 25: Japan MASH Treatment Market, Segmentation By Disease Stage, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 26: Australia MASH Treatment Market, Segmentation By Treatment, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 27: Australia MASH Treatment Market, Segmentation By End-User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 28: Australia MASH Treatment Market, Segmentation By Disease Stage, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 29: Indonesia MASH Treatment Market, Segmentation By Treatment, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 30: Indonesia MASH Treatment Market, Segmentation By End-User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 31: Indonesia MASH Treatment Market, Segmentation By Disease Stage, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 32: South Korea MASH Treatment Market, Segmentation By Treatment, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 33: South Korea MASH Treatment Market, Segmentation By End-User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 34: South Korea MASH Treatment Market, Segmentation By Disease Stage, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 35: Western Europe MASH Treatment Market, Segmentation By Treatment, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 36: Western Europe MASH Treatment Market, Segmentation By End-User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 37: Western Europe MASH Treatment Market, Segmentation By Disease Stage, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 38: UK MASH Treatment Market, Segmentation By Treatment, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 39: UK MASH Treatment Market, Segmentation By End-User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 40: UK MASH Treatment Market, Segmentation By Disease Stage, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 41: Germany MASH Treatment Market, Segmentation By Treatment, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 42: Germany MASH Treatment Market, Segmentation By End-User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 43: Germany MASH Treatment Market, Segmentation By Disease Stage, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 44: France MASH Treatment Market, Segmentation By Treatment, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 45: France MASH Treatment Market, Segmentation By End-User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 46: France MASH Treatment Market, Segmentation By Disease Stage, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 47: Italy MASH Treatment Market, Segmentation By Treatment, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 48: Italy MASH Treatment Market, Segmentation By End-User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 49: Italy MASH Treatment Market, Segmentation By Disease Stage, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 50: Spain MASH Treatment Market, Segmentation By Treatment, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 51: Spain MASH Treatment Market, Segmentation By End-User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 52: Spain MASH Treatment Market, Segmentation By Disease Stage, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 53: Eastern Europe MASH Treatment Market, Segmentation By Treatment, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 54: Eastern Europe MASH Treatment Market, Segmentation By End-User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 55: Eastern Europe MASH Treatment Market, Segmentation By Disease Stage, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 56: Russia MASH Treatment Market, Segmentation By Treatment, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 57: Russia MASH Treatment Market, Segmentation By End-User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 58: Russia MASH Treatment Market, Segmentation By Disease Stage, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 59: North America MASH Treatment Market, Segmentation By Treatment, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 60: North America MASH Treatment Market, Segmentation By End-User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 61: North America MASH Treatment Market, Segmentation By Disease Stage, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 62: USA MASH Treatment Market, Segmentation By Treatment, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 63: USA MASH Treatment Market, Segmentation By End-User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 64: USA MASH Treatment Market, Segmentation By Disease Stage, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 65: Canada MASH Treatment Market, Segmentation By Treatment, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 66: Canada MASH Treatment Market, Segmentation By End-User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 67: Canada MASH Treatment Market, Segmentation By Disease Stage, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 68: South America MASH Treatment Market, Segmentation By Treatment, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 69: South America MASH Treatment Market, Segmentation By End-User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 70: South America MASH Treatment Market, Segmentation By Disease Stage, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 71: Brazil MASH Treatment Market, Segmentation By Treatment, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 72: Brazil MASH Treatment Market, Segmentation By End-User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 73: Brazil MASH Treatment Market, Segmentation By Disease Stage, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 74: Middle East MASH Treatment Market, Segmentation By Treatment, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 75: Middle East MASH Treatment Market, Segmentation By End-User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 76: Middle East MASH Treatment Market, Segmentation By Disease Stage, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 77: Africa MASH Treatment Market, Segmentation By Treatment, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 78: Africa MASH Treatment Market, Segmentation By End-User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 79: Africa MASH Treatment Market, Segmentation By Disease Stage, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 80: Global MASH Treatment, Key Competitor Estimated Market Shares, 2024, Percentage (%)
    • Figure 81: Geographic Regions Covered

    Advanced Therapy Medicinal Products Industry Poised for Rapid Expansion, Projected to Hit $104.43 Billion by 2029

    Read More About Advanced Therapy Medicinal Products Industry Poised for Rapid Expansion, Projected to Hit $104.43 Billion by 2029

    Global Insights: Androgen Deprivation Therapy Market Expected to Surpass $10.49 Billion by 2029

    Read More About Global Insights: Androgen Deprivation Therapy Market Expected to Surpass $10.49 Billion by 2029

    2025 Anti-CD20 Monoclonal Antibodies Market Outlook: Opportunities, Growth Trends, and Strategic Analysis

    Read More About 2025 Anti-CD20 Monoclonal Antibodies Market Outlook: Opportunities, Growth Trends, and Strategic Analysis

    Future Projections: Anti-D Immunoglobulin Market to Reach $3.34 Billion by 2029 at 6.6% CAGR

    Read More About Future Projections: Anti-D Immunoglobulin Market to Reach $3.34 Billion by 2029 at 6.6% CAGR

    Anti-Inflammatory Biologics Market Revenue Outlook: Strategic Insights and Forecast to 2029

    Read More About Anti-Inflammatory Biologics Market Revenue Outlook: Strategic Insights and Forecast to 2029

    CAGR of 10.8% Projected for Anti-Tumor Drugs Market From 2025 to 2029

    Read More About CAGR of 10.8% Projected for Anti-Tumor Drugs Market From 2025 to 2029

    Future Demand and Leading Companies Shaping the Asthma Disease Market to 2029

    Read More About Future Demand and Leading Companies Shaping the Asthma Disease Market to 2029

    Comprehensive Forecast: Asthma Therapeutics Market Share, Growth, and Opportunities Through 2029

    Read More About Comprehensive Forecast: Asthma Therapeutics Market Share, Growth, and Opportunities Through 2029

    CAR-T Therapy Market 2021 - By Target Antigen (CD19, CD22, BCMA), By Application (Acute Lymphoblastic Leukemia, Diffuse Large B-Cell Lymphoma, Follicular Lymphoma, Chronic Lymphocytic Leukemia, Multiple Myeloma), And By ...

    Central Nervous System Drugs Market 2021 - By Type (Multiple Sclerosis (MS), Anti-Psychotic, Analgesics, Anti-Parkinson Drugs, Anesthetics, Anti-Epileptics, Anti-Depressants, Other CNS Drugs), By Distribution Channel (Ho...

    Pharmaceutical Drugs Market 2024 – By Type (Cardiovascular Drugs, Dermatology Drugs, Gastrointestinal Drugs, Genito-Urinary Drugs, Hematology Drugs, Anti-Infective Drugs, Metabolic Disorder Drugs, Musculoskeletal Disorde...

    Oncology Drugs Market 2023 – By Type (Lung Cancer, Pancreatic Cancer, Breast Cancer, Prostate Cancer, Ovarian Cancer, Colorectal Cancer, Gastric Cancer, Kidney Cancer, Brain Tumor, Thyroid Cancer, Skin Cancer, Bladder Ca...

    Dry Eye Medication Market 2021 - By Prescription Type (OTC Drugs, Prescription Drugs) By Drug Variation (Branded, Generic) By Type Of Product (Aqueous, Evaporative, Aqueous And Evaporative) By Distribution Channel (Hospi...

    Cellular Immunotherapy Market Report 2026 - Global Outlook – By Therapy (Tumor-Infiltrating Lymphocyte (TIL) Therapy, Engineered T Cell Receptor (TCR) Therapy, Chimeric Antigen Receptor (CAR) T Cell Therapy, Natural Kill...

    Oral Biologics & Biosimilar Drugs Market Report 2026 - Global Outlook – By Therapy (Lymphocyte Modulators, Interleukin Inhibitors, Tumor Necrosis Factor-Alpha Inhibitors), By Disease (Asthma, Crohn's Disease, Carcinoma, ...

    Monoclonal Antibodies (MAs) Market Report 2026 - Global Outlook – By Source (Murine, Chimeric, Humanized, Human), By Application (Anti-Cancer, Immunological, Anti-Infective Monoclonal Antibodies (MAs), Neuropharmacologic...

    Back to top